Tango Therapeutics Inc (TNGX)
7.61
+0.02
(+0.26%)
USD |
NASDAQ |
May 03, 16:00
7.615
0.00 (0.00%)
After-Hours: 20:00
Tango Therapeutics Total Assets (Quarterly): 402.57M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 402.57M |
| September 30, 2023 | 428.19M |
| June 30, 2023 | 379.33M |
| March 31, 2023 | 403.77M |
| December 31, 2022 | 436.47M |
| September 30, 2022 | 464.16M |
| Date | Value |
|---|---|
| June 30, 2022 | 448.40M |
| March 31, 2022 | 471.52M |
| December 31, 2021 | 500.16M |
| September 30, 2021 | 530.14M |
| December 31, 2020 | 207.25M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
207.25M
Minimum
Dec 2020
530.14M
Maximum
Sep 2021
424.72M
Average
436.47M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| Aquestive Therapeutics Inc | 57.42M |
| 2seventy bio Inc | 565.43M |
| NovaBay Pharmaceuticals Inc | 9.034M |
| Palatin Technologies Inc | 13.55M |
| iBio Inc | 34.02M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 149.46M |
| Shareholders Equity (Quarterly) | 253.11M |
| Current Ratio | 7.544 |